China Healthwise Holdings Limited provided earnings guidance for the year ended December 31, 2021. For the year, the group expects to record a significant increase in loss attributable to owners of the Company within a range of approximately HKD 100 million to approximately HKD 110 million as compared to a loss attributable to owners of the Company of HKD 25 million for the year ended December 31, 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.064 HKD | +20.75% | 0.00% | +56.10% |
03-26 | China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-21 | China Healthwise to Widen Losses in 2023 | MT |
1st Jan change | Capi. | |
---|---|---|
+56.10% | 5.23M | |
-0.72% | 24.26B | |
+15.06% | 8.74B | |
+1.47% | 8.21B | |
-31.14% | 6.87B | |
+19.11% | 5.29B | |
+1.24% | 4.13B | |
-9.24% | 3.79B | |
-8.91% | 3.34B | |
+7.11% | 3.2B |
- Stock Market
- Equities
- 348 Stock
- News China Healthwise Holdings Limited
- China Healthwise Holdings Limited Provides Earnings Guidance for the Year Ended December 31, 2021